Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.

Zhang XY, Zhou DF, Shen YC, Zhang PY, Zhang WF, Liang J, Chen DC, Xiu MH, Kosten TA, Kosten TR.

Neuropharmacology. 2012 Apr;62(5-6):1928-34. doi: 10.1016/j.neuropharm.2011.12.014.

PMID:
22227558
2.
3.

Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics.

Zhang XY, Zhou DF, Qi LY, Chen S, Cao LY, Chen DC, Xiu MH, Wang F, Wu GY, Lu L, Kosten TA, Kosten TR.

Psychopharmacology (Berl). 2009 May;204(1):177-84. doi: 10.1007/s00213-008-1447-6.

PMID:
19139851
4.
5.

The effect of risperidone treatment on superoxide dismutase in schizophrenia.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

J Clin Psychopharmacol. 2003 Apr;23(2):128-31.

PMID:
12640213
6.

Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Psychopharmacology (Berl). 2005 Feb;178(1):35-40.

PMID:
15289996
7.

Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia.

See RE, Fido AA, Maurice M, Ibrahim MM, Salama GM.

Biol Psychiatry. 1999 Jun 15;45(12):1653-6.

PMID:
10376128
8.
9.
10.

Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.

Rémillard S, Pourcher E, Cohen H.

J Int Neuropsychol Soc. 2008 Jan;14(1):110-8.

PMID:
18078537
11.

[Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].

López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL Jr, González Pinto A, Eguiluz I, Fernández A.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Jul-Aug;24(4):165-72. Spanish.

PMID:
8984849
12.

Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients.

Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.

J Psychiatr Res. 2008 Mar;42(4):328-35.

PMID:
17412363
13.

Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study.

Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC.

Int Clin Psychopharmacol. 2001 Nov;16(6):325-30.

PMID:
11712620
14.

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings.

Kee KS, Kern RS, Marshall BD Jr, Green MF.

Schizophr Res. 1998 May 25;31(2-3):159-65.

PMID:
9689720
15.
17.
18.

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.

Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF.

Schizophr Res. 2006 Jan 31;81(2-3):291-300.

PMID:
16309894
19.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia..

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
20.

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

Yao JK, Reddy R, McElhinny LG, van Kammen DP.

J Psychiatr Res. 1998 Nov-Dec;32(6):385-91.

PMID:
9844955
Items per page

Supplemental Content

Support Center